LDS/Medical Tests/NHP2 Gene Mutation Analysis

NHP2 Gene Mutation Analysis

NHP2 gene is a member of the H/ACA snoRNP (small nucleolar ribonuclear proteins) and is located on the long arm of chromosome 5 (5q35.3). This gene codes for the NHP2 protein which is required for ribosome biogenesis and telomere maintenance. This protein is localized into the dense fibrillary components of the nucleoli and coiled bodies (Cajal) of the nucleus. Both 18s rRNA and RNA pseudouridylation are impaired if this protein is depleted which results in decreased RNA-telomerase binding that is required for telomere maintenance.

Mutations of NHP2 gene leads to autosomal recessive dyskeratosis congenita (DC), a rare multisystem disorder caused by defective telomere maintenance. It is characterized by the classical triad of lacy reticulated skin hyperpigmentation, dysplastic nails, and oral leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Patients with DC are at increased risk for myelodysplasia, acute myeloid leukemia and bone marrow failure.

  • As an aid in diagnosis of autosomal recessive dyskeratosis congenita
  • Carrier screening of family members at risk
  • Assessment of asymptomatic carrier status
  • Positive: Mutation or pathogenic variant in NHP2 gene
  • Negative: No mutation or pathogenic variant in NHP2 gene.

Negative for mutation analysis. (No pathogenic variant or mutants detected)

Sequence analysis by Next Generation Sequencing (NGS) or Massively Parallel Sequencing (MPS) and gene targeted deletion/duplication analysis or sequence analysis of entire coding system.

Cell culture, Peripheral whole blood, Saliva, Skin biopsy. 

Stability (Whole blood)

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: unacceptable.
Pathogenic variants analysis in DKC1, ACD, TERC, TERT, CTC1, NOLA3, WRAP53, GAR1 genes, CBC, telomere defect panel, bone marrow biopsy, multicolor flow cytometry and leukocyte fluorescence in situ hybridization (flow-FISH).
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • GeneReviews®, 2019. [PMID: 20301779]
  • Hematology Am Soc Hematol Educ Program. 2011; 2011:480-6. [PMID: 22160078]
  • Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8073-8. [PMID: 18523010]
  • Hum Mol Genet. 2010 Mar 1;19(5):825-36. [PMID: 20008900]
  • Ayas, M. and Ahmed, S. O. (2017) “Dyskeratosis Congenita,” in Congenital and Acquired Bone Marrow Failure. Elsevier, pp. 225–233.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login